(+)-Usnic acid and its salts, inhibitors of SARS‐CoV‐2, identified by using in silico methods and in vitro assay

The pandemic caused by severe acute respiratory Coronavirus-2 (SARS-CoV-2) has been ongoing for over two years, and treatment for COVID-19, other than monoclonal antibodies, is urgently required. Accordingly, we have investigated the inhibitors of SARS-CoV-2 protein targets by high-throughput virtua...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Eunseok, Wang, Weihong, Park, Kyu-Hyung, Park, Chanyoon, Cho, Youbin, Lee, JunI, Kang, Eunmo, Kang, Heonjoong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338942/
https://www.ncbi.nlm.nih.gov/pubmed/35908082
http://dx.doi.org/10.1038/s41598-022-17506-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338942/
https://www.ncbi.nlm.nih.gov/pubmed/35908082
http://dx.doi.org/10.1038/s41598-022-17506-3

Ejemplares similares